 | • レポートコード：MRC2204A168 • 出版社/出版日：Transparency Market Research / 2022年2月 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、世界の再生医療市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、技術別（幹細胞、生体材料、ヒト組織工学）分析、用途別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界の再生医療市場規模：技術別（幹細胞、生体材料、ヒト組織工学） ・世界の再生医療市場規模：用途別 ・世界の再生医療市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Regenerative Medicine Market – Scope of Report
TMR’s report on the global regenerative medicine market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global regenerative medicine market for the period 2017–2028, considering 2018 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global regenerative medicine market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global regenerative medicine market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global regenerative medicine market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global regenerative medicine market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global regenerative medicine market.
The report delves into the competition landscape of the global regenerative medicine market. Key players operating in the global regenerative medicine market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global regenerative medicine market that have been profiled in this report.
Key Questions Answered in Regenerative Medicine Market Report
What is the scope of growth of product companies in the global regenerative medicine market?
What will be the Y-o-Y growth of the global regenerative medicine market between 2021 and 2028?
What is the influence of changing trends in technologies on the global regenerative medicine market?
Will North America continue to be the most profitable market for regenerative medicine devices providers?
Which factors are anticipated to hamper the growth of the global regenerative medicine market during the forecast period?
Which are the leading companies in the global regenerative medicine market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global regenerative medicine market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global regenerative medicine market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the regenerative medicine market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the regenerative medicine market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global regenerative medicine market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global regenerative medicine market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Regenerative Medicines Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Regenerative Medicines Market Analysis and Forecast, 2017–2028
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemics Impact on Industry
6. Global Regenerative Medicines Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Technology, 2017–2028
6.3.1. Stem Cell
6.3.2. Biomaterial
6.3.3. Tissue Engineering
6.4. Market Attractiveness Analysis, by Technology
7. Global Regenerative Medicines Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2028
7.3.1. Bone Graft Substitutes
7.3.2. Osteoarticular Diseases
7.3.3. Allogeneic Bones
7.3.4. Autogenic Bones
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Regenerative Medicines Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Regenerative Medicines Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Technology, 2017–2028
9.2.1. Stem Cell
9.2.2. Biomaterial
9.2.3. Tissue Engineering
9.3. Market Value Forecast, by Application, 2017–2028
9.3.1. Bone Graft Substitutes
9.3.2. Osteoarticular Diseases
9.3.3. Allogeneic Bones
9.3.4. Autogenic Bones
9.3.5. Others
9.4. Market Value Forecast, by Country, 2017–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Technology
9.5.2. By Application
9.5.3. By Country
10. Europe Regenerative Medicines Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technology, 2017–2028
10.2.1. Stem Cell
10.2.2. Biomaterial
10.2.3. Tissue Engineering
10.3. Market Value Forecast, by Application, 2017–2028
10.3.1. Bone Graft Substitutes
10.3.2. Osteoarticular Diseases
10.3.3. Allogeneic Bones
10.3.4. Autogenic Bones
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Technology
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Regenerative Medicines Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technology, 2017–2028
11.2.1. Stem Cell
11.2.2. Biomaterial
11.2.3. Tissue Engineering
11.3. Market Value Forecast, by Application, 2017–2028
11.3.1. Bone Graft Substitutes
11.3.2. Osteoarticular Diseases
11.3.3. Allogeneic Bones
11.3.4. Autogenic Bones
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Technology
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Regenerative Medicines Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technology, 2017–2028
12.2.1. Stem Cell
12.2.2. Biomaterial
12.2.3. Tissue Engineering
12.3. Market Value Forecast, by Application, 2017–2028
12.3.1. Bone Graft Substitutes
12.3.2. Osteoarticular Diseases
12.3.3. Allogeneic Bones
12.3.4. Autogenic Bones
12.3.5. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2028
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Technology
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Regenerative Medicines Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technology, 2017–2028
13.2.1. Stem Cell
13.2.2. Biomaterial
13.2.3. Tissue Engineering
13.3. Market Value Forecast, by Application, 2017–2028
13.3.1. Bone Graft Substitutes
13.3.2. Osteoarticular Diseases
13.3.3. Allogeneic Bones
13.3.4. Autogenic Bones
13.3.5. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2028
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Technology
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Smith & Nephew plc
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Analysis
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. Anika Therapeutics, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Analysis
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. DePuy Synthes, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Analysis
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Baxter International, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Analysis
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Stryker Corporation
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Analysis
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Medtronic, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Analysis
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Arthrex Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Analysis
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. Zimmer Holdings, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Analysis
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. CONMED Corporation
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Analysis
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
Table 01: Global Regenerative Medicine Market Value (US$ Mn) Forecast, by Technology, 2017–2028
Table 02: Global Regenerative Medicine Market Value (US$ Mn) Forecast, by Application, 2017–2028
Table 03: Global Regenerative Medicine Market Value (US$ Mn) Forecast, by Region, 2017–2028
Table 04: North America Regenerative Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 05: North America Regenerative Medicine Market Value (US$ Mn) Forecast, by Technology, 2017–2028
Table 06: North America Regenerative Medicine Market Value (US$ Mn) Forecast, by Application, 2017–2028
Table 07: Europe Regenerative Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 08: Europe Regenerative Medicine Market Value (US$ Mn) Forecast, by Technology, 2017–2028
Table 09: Europe Regenerative Medicine Market Value (US$ Mn) Forecast, by Application, 2017–2028
Table 10: Asia Pacific Regenerative Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 11: Asia Pacific Regenerative Medicine Market Value (US$ Mn) Forecast, by Technology, 2017–2028
Table 12: Asia Pacific Regenerative Medicine Market Value (US$ Mn) Forecast, by Application, 2017–2028
Table 13: Latin America Regenerative Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 14: Latin America Regenerative Medicine Market Value (US$ Mn) Forecast, by Technology, 2017–2028
Table 15: Latin America Regenerative Medicine Market Value (US$ Mn) Forecast, by Application, 2017–2028
Table 16: Middle East & Africa Regenerative Medicine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 17: Middle East & Africa Regenerative Medicine Market Value (US$ Mn) Forecast, by Technology, 2017–2028
Table 18: Middle East & Africa Regenerative Medicine Market Value (US$ Mn) Forecast, by Application, 2017–2028